Banned medicine (Credit-Canva)
The Union Health Ministry implemented a ban on 156 "irrational" FDC medicines, effective immediately. These medicines, including widely used antibiotics, painkillers, and multivitamins, were commonly used to treat fever, cough, and infections. The ban was imposed due to the associated health risks and lack of therapeutic justification for the ingredients in these FDCs.
FDCs or fixed-dosed combinations, also known as "cocktail drugs," are medications that combine multiple drugs in a single pill. They are designed to treat multiple symptoms or conditions simultaneously. While they offer convenience, they can pose significant risks. These risks include the possibility of overdose, adverse interactions between the drugs, and the development of antibiotic resistance. Additionally, many FDC medicines lack sufficient scientific evidence to support their safety and efficacy.
Experts have raised concerns about the use of FDC medicines. They believe that many of these combinations lack sufficient scientific evidence to support their safety and effectiveness. Additionally, the combination of multiple drugs in a single pill can increase the risk of adverse side effects and interactions with other medications.
Experts have also found that FDC medicines may not be as effective as individual drugs in treating certain conditions. It is important to note that safer and more effective alternatives are available for most of the medical conditions that FDC medicines were used to treat. One particular concern is the inclusion of antibiotics in some FDCs. Overuse of antibiotics can contribute to the development of antibiotic resistance, a major public health threat.
The use of FDC medicines can lead to adverse effects, including serious ones. Additionally, safer alternatives, tested in clinical trials, are available to treat the same medical conditions. Experts recommend prescribing drugs individually based on a patient's clinical symptoms rather than combining them in FDCs.
The ban on irrational FDC medicines by the Union Health Ministry can be seen as a positive step towards promoting rational drug use and protecting public health. The goal is to eliminate unnecessary and potentially harmful drug combinations. This is a step forward in reducing the risks associated with medication and ensure safer and more effective treatment options for patients.
Credit: iStock
The Donald Trump administration plans to end Medicare Part D premium subsidies after 2026, ending a program that has helped keep prescription drug plan premiums stable, according to the Centers for Medicare & Medicaid Services (CMS).
The decision could affect millions of Americans, particularly those aged 65 and older, who may face higher prescription drug costs beginning next year.
The CMS said its review of insurers' 2027 bids found that health plans now have sufficient experience to accurately price Medicare Part D plans without government support, according to The Wall Street Journal.
The program, to end after 2026, provides insurance companies with an estimated $3.6 billion in subsidies this year to limit premium increases for Part D plans.
"We are stabilizing the market so this bailout is no longer needed. Premiums will go up by less than $10 for most Medicare recipients, with many even seeing lower premiums," CMS Administrator Dr. Mehmet Oz said in a post on X.
"Every Medicare beneficiary still has access to low-cost plans, and we will continue to lower prescription drug prices for every American patient, from more MFN deals to our policy giving seniors access to GLP-1s for $50 a month,” he added.
Around 25 million Americans enrolled in traditional Medicare have stand-alone Part D prescription drug plans, paying an average monthly premium of $36, according to KFF.
Another 31 million beneficiaries receive prescription drug coverage through Medicare Advantage, the privately managed alternative for people aged 65 and older.
The previous Biden administration had introduced the subsidy program ahead of the 2024 presidential election to offset policy changes that would have sharply increased Medicare Part D premiums in 2025.
Dr Oz said that the Biden administration’s approach was “unacceptable” and that it “gave BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies.”
However, it remains unclear how many beneficiaries will pay more or how large those increases will be. Premiums vary by plan, and beneficiaries will have an opportunity to compare and switch coverage during this fall's enrollment period. CMS said premiums for individual plans will be released in September.
AHIP, a major trade group representing health insurers, said it is reviewing the announcement, the New York Times reported.
“At a time of sharply rising prescription drug costs, health plans are focused on keeping Part D coverage and benefits as affordable as possible,” said Chris Bond, a spokesman, in a statement.
A Trump administration official told Bloomberg that the majority of older Americans will see no increase in premiums or may even pay less.
CMS also released preliminary information on 2027 Medicare drug plan bids. The national average monthly bid amount, used to calculate government subsidies for plans, will be $296.05 in 2027.
The agency said the national base beneficiary premium for Medicare Part D will be $41.33 next year. Annual increases will remain capped at 6% through 2029 under provisions of the Inflation Reduction Act.
Credit: X
More than six years after the COVID-19 pandemic devastated the world, newly released personal journals of former National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci are giving a raw glimpse into the behind-the-scenes discussions, scientific uncertainty, and political tensions that clouded United States' pandemic response.
The 1,141-page collection, released by Senator Rand Paul ahead of Fauci's scheduled Senate testimony, chronicles events from December 2019 through December 2022.
Announcing the release of Fauci's journals, Sen. Rand Paul said, "The American people deserve the truth about what happened during the COVID-19 pandemic. Dr. Fauci's own contemporaneous writings provide an unprecedented window into the decisions, discussions, and uncertainties that shaped the federal response."
The journals have reignited debate over the origins of SARS-CoV-2 and Fauci's role during one of the most challenging public health crises of recent times.
However, experts say that the diaries represent Fauci's personal contemporaneous notes and do not conclusively establish the origin of COVID-19.
One of the biggest revelations is that Anthony Fauci recorded discussions in late January 2020 in which several scientists raised questions about whether SARS-CoV-2 could have originated from a laboratory because of certain genetic features.
The diary shows these possibilities were discussed internally before scientists later concluded that natural spillover was the more likely. The diary does not provide proof that the virus leaked from a lab.
Fauci wrote, "The first infection was in early December and was not connected to the market... Now we know the market was not the source, it was the amplifier. Having said that, somewhere the virus jumped from animals to humans."
Also read: Trump Should Take A Month Off For His Health, Says Bill O'Reilly
The entries reveal Fauci continued receiving updates about the virus's origin while publicly emphasizing the available scientific evidence supporting natural emergence.
After a conference call with leading virologists, Fauci wrote that several experts discussed whether part of the virus genome could have evolved naturally. He listed the participants and summarized the debate over the possibility of a laboratory origin.
Early diary entries describe the outbreak as looking similar to "bad influenza" before severe complications became clear. This reflects the limited knowledge available in January and early February 2020.
Fauci's notes reportedly show he was conflicted about balancing infection control against the educational and mental health consequences of prolonged school closures, highlighting the uncertainty policymakers faced.
The diary documents Fauci's concerns about bureaucratic delays, operational problems, and disagreements within the federal government during the early COVID-19 response, suggesting these challenges complicated public health decision-making.
The entries describe Fauci's dynamic with President Donald Trump, disagreements over masks, hydroxychloroquine, and public messaging, and concerns about how politics affected science.
He wrote, "AMAZING interaction with POTUS... It was a disturbingly rambling discussion since he kept talking about TV ratings, and HC (Hydroxychloroquine), and influenza and virtually everything else as I was trying to keep him on track."
He also wrote about outshining President Trump. "Apparently the WH is very upset that I am being profiled and it looks like I am putting down the POTUS and becoming a star that outshines him. ... Very stressful!!"
He also wrote that Trump praised him. "As usual, POTUS was very warm and friendly with me... 'I love you, Tony. I feel like giving you a big hug.'"
The journals reveal Fauci's obsession with his fame due to widespread media coverage and his efforts to maintain public trust. He wrote, "For better or worse, I am becoming an international celebrity. Calls from all over the world."
He added, "WH press conference picked up by many outlets. Many print profiles and features on me. Ridiculous, too numerous to count! ... Press is going wild with me."
Fauci's diary sparked a lot of responses from politicians and health experts.
He said, "He lied about masks. He lied about social distancing. He lied about transmission. He lied about natural immunity. He lied about the vaccine's capacity to prevent infection."
He added. "Dr. Fauci did incalculable damage to public health and to the public's trust in government. "He prioritized getting on TV over protecting public health."
Credit: X
Olympic hurdler and bobsledder Lolo Jones has revealed that she suffered a debilitating spinal injury during bobsled training, lost bladder control, and was allegedly denied timely medical care, raising serious concerns about athlete health and safety within the U.S. Olympic system.
Jones shared her experience after reports of the the events surrounding a training accident ahead of the 2025 IBSF World Championships in Lake Placid surfaced.
According to the reports, she sustained a severe lower back injury while testing a new bobsled but continued competing because her condition was never diagnosed at the time.
During the training session, Lolo Jones experienced symptoms like intense lower back pain, numbness, leg weakness, foot drop, and loss of bladder control; all of which can be warning signs of cauda equina syndrome, a rare but serious condition caused by compression of nerves at the base of the spinal cord.
It is a medical emergency as delayed treatment can result in permanent paralysis or loss of bladder and bowel function.
Despite these symptoms, Jones alleges she did not receive urgent medical evaluation. Reports claim that when she visited the U.S. Olympic Training Center's sports medicine clinic seeking treatment, her scheduled massage appointment had been canceled, and she was not provided immediate imaging such as an MRI or X-ray.
Convinced she was dealing with a painful but manageable injury, Jones continued to compete in the World Championships, completing multiple high-speed bobsled runs. She later said that had the sled crashed during competition, she could have been left permanently paralysed.
After returning home, Jones reportedly paid for her own MRI, which revealed the extent of the damage. The scan showed a herniated disc, additional disc bulges, and tears involving the L3, L4 and L5 levels of her spine, with leaking spinal fluid. She subsequently underwent spinal surgery at her own expense.
Jones also claims that after surgery she was denied access to training and rehabilitation facilities at the Olympic Training Center, forcing her to fund her own recovery, rehabilitation, travel and training. According to reports, the financial burden exceeded $100,000.
The athlete has since called for greater accountability and reforms in athlete medical care, especially who compete in the Olympics.
In a public statement, Jones wrote that she had "never even been given an X-ray or an MRI" despite her symptoms and said she wanted to help ensure other athletes do not face similar situations.
Experts consider loss of bladder control, leg weakness, numbness around the saddle area, and severe lower back pain to be serious symptoms that need immediate emergency assessment.
Prompt diagnosis, usually with an MRI, and urgent surgery when cauda equina syndrome is confirmed can significantly improve the chances of preserving nerve function and preventing the risk of paralysis.
Jones is one of the few athletes to have competed at both the Summer and Winter Olympics, representing the United States in hurdles and bobsled.
Her latest allegations have sparked renewed discussion about whether elite athletes receive timely access to appropriate medical attention when serious injuries occur.
© 2024 Bennett, Coleman & Company Limited